Molecular Partners Competitors and Similar CompaniesClear all
Molecular Partners's competitors and similar companies include Brii Biosciences and Abliva.
 Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 2004 | Founding Date 2018 | Founding Date 2000 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Lund, SE HQ |
Employees | Employees 158 | Employees 8510% decrease | Employees 950% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr497k (FY, 2024) |
Net income | Net income (CHF61.7m) (FY, 2025) | Net income N/A | Net income (kr90m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 415m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
Brii Biosciences
HQ
CN
Employees
85↓ 10% decrease
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company